Market Closed -
NSE India S.E.
07:43:52 2024-05-15 am EDT
|
5-day change
|
1st Jan Change
|
2,474
INR
|
-0.72%
|
|
+6.50%
|
-4.03%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
87,034
|
115,422
|
223,265
|
215,706
|
151,339
|
206,929
|
-
|
-
|
Enterprise Value (EV)
1 |
80,283
|
108,088
|
213,412
|
212,332
|
145,552
|
187,931
|
197,210
|
192,912
|
P/E ratio
|
43.2
x
|
51.2
x
|
76.8
x
|
62.8
x
|
63.6
x
|
52.6
x
|
49.9
x
|
43
x
|
Yield
|
0.57%
|
0.86%
|
0.52%
|
0.46%
|
0.66%
|
0.68%
|
0.88%
|
0.92%
|
Capitalization / Revenue
|
7.23
x
|
8.68
x
|
14.1
x
|
10.3
x
|
7.5
x
|
8.44
x
|
8.29
x
|
7.44
x
|
EV / Revenue
|
6.67
x
|
8.12
x
|
13.5
x
|
10.2
x
|
7.22
x
|
8.44
x
|
7.9
x
|
6.94
x
|
EV / EBITDA
|
27.3
x
|
31.5
x
|
48.9
x
|
37.9
x
|
29.7
x
|
30.8
x
|
29
x
|
25.3
x
|
EV / FCF
|
43.7
x
|
45.6
x
|
58.9
x
|
60.2
x
|
34.7
x
|
47.4
x
|
39.7
x
|
33.4
x
|
FCF Yield
|
2.29%
|
2.19%
|
1.7%
|
1.66%
|
2.88%
|
2.11%
|
2.52%
|
3%
|
Price to Book
|
9.11
x
|
11.3
x
|
18.1
x
|
14.4
x
|
9.15
x
|
11
x
|
10
x
|
8.72
x
|
Nbr of stocks (in thousands)
|
83,342
|
82,344
|
82,475
|
82,624
|
82,785
|
83,051
|
-
|
-
|
Reference price
2 |
1,044
|
1,402
|
2,707
|
2,611
|
1,828
|
2,492
|
2,492
|
2,492
|
Announcement Date
|
5/17/19
|
5/18/20
|
5/21/21
|
5/17/22
|
5/11/23
|
5/10/24
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
12,034
|
13,304
|
15,813
|
20,874
|
20,169
|
22,266
|
24,961
|
27,800
|
EBITDA
1 |
2,936
|
3,436
|
4,363
|
5,607
|
4,899
|
6,093
|
6,789
|
7,623
|
EBIT
1 |
2,554
|
2,708
|
3,591
|
4,526
|
3,397
|
4,657
|
5,265
|
6,013
|
Operating Margin
|
21.22%
|
20.35%
|
22.71%
|
21.68%
|
16.84%
|
20.92%
|
21.09%
|
21.63%
|
Earnings before Tax (EBT)
1 |
3,006
|
3,105
|
3,944
|
4,749
|
3,439
|
5,055
|
5,792
|
6,676
|
Net income
1 |
2,005
|
2,276
|
2,916
|
3,448
|
2,389
|
3,577
|
4,176
|
4,842
|
Net margin
|
16.66%
|
17.11%
|
18.44%
|
16.52%
|
11.84%
|
16.06%
|
16.73%
|
17.42%
|
EPS
2 |
24.15
|
27.37
|
35.25
|
41.57
|
28.74
|
42.98
|
49.98
|
57.98
|
Free Cash Flow
1 |
1,837
|
2,368
|
3,626
|
3,526
|
4,195
|
4,208
|
4,965
|
5,781
|
FCF margin
|
15.26%
|
17.8%
|
22.93%
|
16.89%
|
20.8%
|
18.84%
|
19.89%
|
20.79%
|
FCF Conversion (EBITDA)
|
62.57%
|
68.92%
|
83.1%
|
62.88%
|
85.63%
|
69.19%
|
73.13%
|
75.83%
|
FCF Conversion (Net income)
|
91.62%
|
104.04%
|
124.34%
|
102.26%
|
175.6%
|
118.2%
|
118.9%
|
119.4%
|
Dividend per Share
2 |
6.000
|
12.00
|
14.00
|
12.00
|
12.00
|
16.89
|
21.98
|
22.93
|
Announcement Date
|
5/17/19
|
5/18/20
|
5/21/21
|
5/17/22
|
5/11/23
|
5/10/24
|
-
|
-
|
Fiscal Period: March |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
4,524
|
4,310
|
6,066
|
4,984
|
4,969
|
4,855
|
5,027
|
5,338
|
4,894
|
4,910
|
5,410
|
5,898
|
5,588
|
5,469
|
6,091
|
EBITDA
1 |
1,388
|
1,220
|
1,890
|
1,415
|
1,092
|
1,211
|
1,175
|
1,438
|
1,130
|
1,156
|
1,462
|
1,600
|
1,468
|
1,403
|
1,843
|
EBIT
1 |
1,193
|
1,017
|
1,844
|
1,210
|
785
|
834
|
816
|
1,050
|
751
|
780
|
1,111
|
1,288
|
1,083
|
1,077
|
1,355
|
Operating Margin
|
26.37%
|
23.6%
|
30.4%
|
24.28%
|
15.8%
|
17.18%
|
16.23%
|
19.67%
|
15.35%
|
15.89%
|
20.54%
|
21.83%
|
19.38%
|
19.7%
|
22.25%
|
Earnings before Tax (EBT)
1 |
1,289
|
1,108
|
1,793
|
1,306
|
815
|
835
|
814
|
1,028
|
765
|
832
|
1,175
|
1,335
|
1,200
|
1,099
|
1,623
|
Net income
1 |
945
|
834
|
1,312
|
950
|
573
|
613
|
577
|
717
|
528
|
567
|
826
|
928.4
|
855.3
|
816.8
|
1,166
|
Net margin
|
20.89%
|
19.35%
|
21.63%
|
19.06%
|
11.53%
|
12.63%
|
11.48%
|
13.43%
|
10.79%
|
11.55%
|
15.27%
|
15.74%
|
15.31%
|
14.94%
|
19.14%
|
EPS
2 |
11.41
|
10.07
|
15.84
|
11.45
|
6.900
|
7.380
|
6.960
|
8.600
|
6.350
|
6.820
|
9.930
|
11.51
|
10.32
|
9.749
|
14.01
|
Dividend per Share
2 |
-
|
8.000
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
12.00
|
-
|
-
|
-
|
10.20
|
-
|
Announcement Date
|
1/29/21
|
5/21/21
|
7/30/21
|
10/26/21
|
2/10/22
|
5/17/22
|
7/28/22
|
11/8/22
|
2/2/23
|
5/11/23
|
7/27/23
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
6,751
|
7,334
|
9,853
|
3,374
|
5,787
|
7,681
|
9,719
|
14,017
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
1,837
|
2,368
|
3,626
|
3,526
|
4,195
|
4,208
|
4,965
|
5,781
|
ROE (net income / shareholders' equity)
|
23.1%
|
23%
|
25.6%
|
25.1%
|
15.1%
|
19.8%
|
21%
|
21.2%
|
ROA (Net income/ Total Assets)
|
20%
|
18.5%
|
19.2%
|
17.2%
|
10.1%
|
13.6%
|
15.3%
|
17%
|
Assets
1 |
10,031
|
12,324
|
15,178
|
20,071
|
23,661
|
26,174
|
27,292
|
28,481
|
Book Value Per Share
2 |
115.0
|
124.0
|
149.0
|
181.0
|
200.0
|
226.0
|
248.0
|
286.0
|
Cash Flow per Share
2 |
26.20
|
34.10
|
48.10
|
53.90
|
54.70
|
55.20
|
62.30
|
74.90
|
Capex
1 |
348
|
471
|
356
|
941
|
365
|
581
|
604
|
730
|
Capex / Sales
|
2.9%
|
3.54%
|
2.25%
|
4.51%
|
1.81%
|
2.6%
|
2.42%
|
2.63%
|
Announcement Date
|
5/17/19
|
5/18/20
|
5/21/21
|
5/17/22
|
5/11/23
|
5/10/24
|
-
|
-
|
Last Close Price
2,492
INR Average target price
2,488
INR Spread / Average Target -0.15% Consensus |
1st Jan change
|
Capi.
|
---|
| -3.44% | 2.48B | | -16.80% | 8.79B | | +63.16% | 4.19B | | -9.81% | 2.45B | | -43.01% | 2.29B | | -4.82% | 1.97B | | -18.74% | 1.56B | | -40.24% | 1.22B | | +9.42% | 1.13B | | +22.12% | 933M |
Medical & Diagnostic Laboratories
|